Accuracy of migraine diagnosis and treatment by neurologists in the Baltic states: e-survey with clinical case challenge.
Accuracy
Anti-CGRP
Burden
Diagnosis
Migraine
Prophylaxis
Treatment
Triptans
Journal
European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857
Informations de publication
Date de publication:
18 Dec 2023
18 Dec 2023
Historique:
received:
20
02
2023
accepted:
27
11
2023
medline:
19
12
2023
pubmed:
19
12
2023
entrez:
19
12
2023
Statut:
epublish
Résumé
Underdiagnosis of migraine causes a significant health burden, including lower quality of life, excessive medication use, and a delay in effective treatment. The purpose of this study was to evaluate migraine diagnosis accuracy and to review the treatment approaches used by neurologists in the Baltic states. The research was conducted as an anonymous e-survey with four cases in March and April 2021. 119 practicing adult neurologists have participated. The migraine diagnostic accuracy was 63.2%. The most commonly used diagnostic criteria were moderate/severe pain, unilateral pain, and disruption of daily activities. Diagnostic accuracy did not differ significantly between neurologists who always use ICHD-3 criteria and those who don't (68.4% vs. 58.5%, p = 0.167). It was higher in neurologists who were working in headache centers (91.7% vs. 60.9%, p = 0.012), and was related to a higher percentage of migraine diagnoses in all consulted headache patients (R Migraine diagnostic accuracy is improved through practical patient counseling and modern treatment prescription. Although the neurologists in the Baltic states follow current European guidelines, there is room for improvement in diagnostic accuracy to reduce migraine burden.
Sections du résumé
BACKGROUND
BACKGROUND
Underdiagnosis of migraine causes a significant health burden, including lower quality of life, excessive medication use, and a delay in effective treatment. The purpose of this study was to evaluate migraine diagnosis accuracy and to review the treatment approaches used by neurologists in the Baltic states.
METHODS
METHODS
The research was conducted as an anonymous e-survey with four cases in March and April 2021.
RESULTS
RESULTS
119 practicing adult neurologists have participated. The migraine diagnostic accuracy was 63.2%. The most commonly used diagnostic criteria were moderate/severe pain, unilateral pain, and disruption of daily activities. Diagnostic accuracy did not differ significantly between neurologists who always use ICHD-3 criteria and those who don't (68.4% vs. 58.5%, p = 0.167). It was higher in neurologists who were working in headache centers (91.7% vs. 60.9%, p = 0.012), and was related to a higher percentage of migraine diagnoses in all consulted headache patients (R
CONCLUSIONS
CONCLUSIONS
Migraine diagnostic accuracy is improved through practical patient counseling and modern treatment prescription. Although the neurologists in the Baltic states follow current European guidelines, there is room for improvement in diagnostic accuracy to reduce migraine burden.
Identifiants
pubmed: 38110980
doi: 10.1186/s40001-023-01555-z
pii: 10.1186/s40001-023-01555-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
600Informations de copyright
© 2023. The Author(s).
Références
Olesen J. Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia. 2018;38:1–211. https://doi.org/10.1177/0333102417738202 .
doi: 10.1177/0333102417738202
Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17:501–14. https://doi.org/10.1038/S41582-021-00509-5 .
doi: 10.1038/S41582-021-00509-5
pubmed: 34145431
pmcid: 8321897
James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858. https://doi.org/10.1016/S0140-6736(18)32279-7 .
doi: 10.1016/S0140-6736(18)32279-7
Buse DC, Armand CE, Charleston L, Reed ML, Fanning KM, Adams AM, et al. Barriers to care in episodic and chronic migraine: Results from the Chronic Migraine Epidemiology and Outcomes Study. Headache. 2021;61:628–41. https://doi.org/10.1111/HEAD.14103 .
doi: 10.1111/HEAD.14103
pubmed: 33797078
Abbafati C, Abbas KM, Abbasi-Kangevari M, Abd-Allah F, Abdelalim A, Abdollahi M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204. https://doi.org/10.1016/S0140-6736(20)30925-9 .
doi: 10.1016/S0140-6736(20)30925-9
Cevoli S, D’amico D, Martelletti P, Valguarnera F, del Bene E, de Simone R, et al. Underdiagnosis and undertreatment of migraine in italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia. 2009;29:1285–93. https://doi.org/10.1111/J.1468-2982.2009.01874.X .
doi: 10.1111/J.1468-2982.2009.01874.X
pubmed: 19438916
Schreiber CP, Hutchinson S, Webster CJ, Ames M, Richardson MS, Powers C. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed “sinus” headache. Arch Intern Med. 2004;164:1769–72. https://doi.org/10.1001/ARCHINTE.164.16.1769 .
doi: 10.1001/ARCHINTE.164.16.1769
pubmed: 15364670
Lebedeva ER, Kobzeva NR, Gilev DV, Olesen J. The quality of diagnosis and management of migraine and tension-type headache in three social groups in Russia. Cephalalgia. 2016;37:225–35. https://doi.org/10.1177/0333102416642603 .
doi: 10.1177/0333102416642603
pubmed: 27053061
Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ. Poor medical care for people with migraine in Europe—evidence from the Eurolight study. J Headache Pain. 2018. https://doi.org/10.1186/S10194-018-0839-1 .
doi: 10.1186/S10194-018-0839-1
pubmed: 30355321
pmcid: 6755563
Ahmed ZA, Faulkner LR. Headache education in adult neurology residency: a survey of program directors and chief residents. Headache. 2016;56:871–7. https://doi.org/10.1111/HEAD.12822 .
doi: 10.1111/HEAD.12822
pubmed: 27040043
Do TP, Dømgaard M, Stefansen S, Kristoffersen ES, Ashina M, Hansen JM. Barriers and gaps in headache education: a national cross-sectional survey of neurology residents in Denmark. BMC Med Educ. 2022. https://doi.org/10.1186/S12909-022-03299-6 .
doi: 10.1186/S12909-022-03299-6
pubmed: 35379230
pmcid: 8978342
Kristoffersen ES, Winsvold BS, Faiz KW. Prestige of neurological disorders among future neurologists in Norway. Acta Neurol Scand. 2019;139:555–8. https://doi.org/10.1111/ANE.13087 .
doi: 10.1111/ANE.13087
pubmed: 30851195
Jokubaitis M, Kõrv J, Karelis G, Jatužis D, Vaitkus A, Ryliškienė K. Subspecialty training of neurology residents and junior neurologists in the Baltic States. Eur J Neurol. 2021;28:3584–90. https://doi.org/10.1111/ENE.14978 .
doi: 10.1111/ENE.14978
pubmed: 34129702
Glavind M, Kristensen H, Thien Do P, Pozo-Rosich P, Faisal AM, et al. Interest in and exposure to headache disorders among neurology residents in Denmark: a nationwide cross-sectional survey. Acta Neurol Scand. 2022;146:568–72. https://doi.org/10.1111/ANE.13681 .
doi: 10.1111/ANE.13681
Viticchi G, Falsetti L, Bartolini M, Buratti L, Ulissi A, Baldassari M, et al. Migraine: incorrect self-management for a disabling disease. Neurol Int. 2018;10:24–7. https://doi.org/10.4081/NI.2018.7510 .
doi: 10.4081/NI.2018.7510
Lublóy Á. Economic burden of migraine in Latvia and Lithuania: direct and indirect costs. BMC Public Health. 2019;19:1–26. https://doi.org/10.1186/S12889-019-7461-2/TABLES/10 .
doi: 10.1186/S12889-019-7461-2/TABLES/10
Peres MFP, Swerts DB, de Oliveira AB, Silva-Neto RP. Migraine patients’ journey until a tertiary headache center: an observational study. J Headache Pain. 2019;20:1–8. https://doi.org/10.1186/S10194-019-1039-3/TABLES/7 .
doi: 10.1186/S10194-019-1039-3/TABLES/7
Lenz B, Katsarava Z, Gil-Gouveia R, Karelis G, Kaynarkaya B, Meksa L, et al. Headache service quality evaluation: implementation of quality indicators in primary care in Europe. J Headache Pain. 2021;22:1–12. https://doi.org/10.1186/S10194-021-01236-4/FIGURES/3 .
doi: 10.1186/S10194-021-01236-4/FIGURES/3
Peters M, Perera S, Loder E, Jenkinson C, Gouveia RG, Jensen R, et al. Quality in the provision of headache care. 1: systematic review of the literature and commentary. J Headache Pain. 2012;13:437–47. https://doi.org/10.1007/S10194-012-0466-1 .
doi: 10.1007/S10194-012-0466-1
pubmed: 22736100
pmcid: 3464474
Schramm S, Uluduz D, Gouveia RG, Jensen R, Siva A, Uygunoglu U, et al. Headache service quality: evaluation of quality indicators in 14 specialist-care centres. J Headache Pain. 2016;17:1–14. https://doi.org/10.1186/S10194-016-0707-9/TABLES/5 .
doi: 10.1186/S10194-016-0707-9/TABLES/5
Dale PC, Thomas JC, Hazle CR. Physical therapist clinical reasoning and classification inconsistencies in headache disorders: a United States survey. J Man Manip Ther. 2019;28:28–40. https://doi.org/10.1080/10669817.2019.1645414 .
doi: 10.1080/10669817.2019.1645414
pubmed: 31373539
pmcid: 7006737
De Diego EV, Lanteri-Minet M. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT). Cephalalgia. 2005;25:184–90. https://doi.org/10.1111/J.1468-2982.2004.00820.X .
doi: 10.1111/J.1468-2982.2004.00820.X
pubmed: 15689193
de Klippel N, Jansen JP, Carlos JS. Survey to evaluate diagnosis and management of headache in primary care: headache management pattern programme. Curr Med Res Opin. 2008;24:3413–22. https://doi.org/10.1185/03007990802547139 .
doi: 10.1185/03007990802547139
pubmed: 19032123
Sheftell FD, Tepper SJ. New paradigms in the recognition and acute treatment of migraine. Headache. 2002;42:58–69. https://doi.org/10.1046/J.1526-4610.2002.02015.X .
doi: 10.1046/J.1526-4610.2002.02015.X
pubmed: 12005277
Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, et al. A self-administered screener for migraine in primary care: the ID migraine validation study. Neurology. 2003;61:375–82. https://doi.org/10.1212/01.WNL.0000078940.53438.83 .
doi: 10.1212/01.WNL.0000078940.53438.83
pubmed: 12913201
Cousins G, Hijazze S, van de Laar FA, Fahey T. Diagnostic accuracy of the ID migraine: a systematic review and meta-analysis. Headache. 2011;51:1140–8. https://doi.org/10.1111/J.1526-4610.2011.01916.X .
doi: 10.1111/J.1526-4610.2011.01916.X
pubmed: 21649653
Evers S, Áfra J, Frese A, Goadsby PJ, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. Eur J Neurol. 2009;16:968–81. https://doi.org/10.1111/J.1468-1331.2009.02748.X .
doi: 10.1111/J.1468-1331.2009.02748.X
pubmed: 19708964
Soni P, Chawla E. Efficacy and safety of anti-calcitonin gene-related peptide monoclonal antibodies for treatment of chronic migraine: a systematic review and network meta-analysis. Clin Neurol Neurosurg. 2021;209:106893. https://doi.org/10.1016/J.CLINEURO.2021.106893 .
doi: 10.1016/J.CLINEURO.2021.106893
pubmed: 34464833
Shi M, Guo J, Li Z, Sun H, Yang X, Yang D, et al. Network meta-analysis on efficacy and safety of different anti-CGRP monoclonal antibody regimens for prophylaxis and treatment of episodic migraine. Neurol Res. 2021;43:932–49. https://doi.org/10.1080/01616412.2021.1940672 .
doi: 10.1080/01616412.2021.1940672
pubmed: 34281473